Summit Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $155k | 7.5k | 20.66 |
| 2025-06-30 | $155k | 7.3k | 21.28 |
| 2025-03-31 | $1.1M | 55k | 19.29 |
| 2024-12-31 | $989k | 55k | 17.85 |
| 2024-09-30 | $1.1M | 51k | 21.90 |
| 2024-06-30 | $401k | 51k | 7.80 |
| 2023-12-31 | $165k | 63k | 2.61 |
| 2023-09-30 | $118k | 63k | 1.87 |
| 2023-06-30 | $159k | 63k | 2.51 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors